Literature DB >> 3069753

Bromocriptine in cocaine withdrawal--does it work?

D W Teller1, P Devenyi.   

Abstract

Heavy cocaine use has been reported to lead to dopamine depletion in the brain, which in turn may be responsible for strong cocaine craving after withdrawal. Bromocriptine, a dopaminergic agonist, was used on that basis to prevent relapses in the withdrawal period. In an uncontrolled trial of 25 heavy cocaine users, measurements of pre- and post-bromocriptine serum prolactin levels-as indicators of inhibitory dopaminergic control-did not suggest dopamine depletion. Moreover, in 13 of these 25 patients, an assessment scale for craving and for other subjective discomforts indicated some improvement in only a slight majority, which is probably inseparable from placebo effect.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3069753     DOI: 10.3109/10826088809056194

Source DB:  PubMed          Journal:  Int J Addict        ISSN: 0020-773X


  2 in total

1.  An endogenous neuroprotectant substance, 1-methyl-1,2,3,4-tetrahydroisoquinoline (1MeTIQ), prevents the behavioral and neurochemical effects of cocaine reinstatement in drug-dependent rats.

Authors:  L Antkiewicz-Michaluk; M Filip; J Michaluk; I Romańska; E Przegaliński; J Vetulani
Journal:  J Neural Transm (Vienna)       Date:  2006-08-10       Impact factor: 3.575

2.  Relationship of serum prolactin with severity of drug use and treatment outcome in cocaine dependence.

Authors:  Ashwin A Patkar; Paolo Mannelli; Kenneth M Certa; Kathleen Peindl; Heather Murray; Michael J Vergare; Wade H Berrettini
Journal:  Psychopharmacology (Berl)       Date:  2004-04-03       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.